On December 8, 2022, closed the transaction. Starting December 9, 2022, the amount equivalent to 90% of the closing price rounded up to the nearest yen will be If the exercise price exceeds or falls below the immediately preceding effective exercise price by 1 yen or more, the exercise price will be revised to the revised price on or after the revision date. However, if the price after such revision falls below ¥457, the minimum exercise price shall be the revised exercise price.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
385 JPY | +0.52% |
|
+1.58% | -26.25% |
1st Jan change | Capi. | |
---|---|---|
-26.25% | 43.28M | |
+38.36% | 52.73B | |
+39.50% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- 4572 Stock
- News Carna Biosciences, Inc.
- Carna Biosciences, Inc. announced that it has received ¥11.209315 million in funding from Cantor Fitzgerald & Co.